Pain Research and Management · 2011 · 15 citations · 10 references
PharmacyPharmacologyPharmacotherapyPain ManagementPain MedicinePsychopharmacologyAdolescent PharmacotherapyAntidepressant PharmacotherapyAntidepressant TherapyPain In AdolescentsPediatric PainPharmacologic Pain TherapyAntidepressant Use In YouthComorbid Depression ManagementConversion SymptomsDiabetic Neuropathic PainDuloxetine TherapyPediatric Pain PharmacotherapyPediatric Peripheral NeuropathyPharmacologic Pain Treatment
In the United States, duloxetine has been approved for the treatment of major depressive disorder, diabetic peripheral neuropathic pain and fibromyalgia in the adult population. Data regarding the use of duloxetine in the pediatric population, however, are very limited. Femoral nerve injury is a rare complication of cardiac catheterization. In the case described, duloxetine contributed to a successful multimodal treatment program for peripheral neuropathic pain due to femoral neuropathy in an adolescent with 'reactive depression' and conversion symptoms. To the best of the authors' knowledge, the present article is only the third such report on this dual use of duloxetine in children and adolescents, and the first report of such treatment following femoral neuropathy induced by cardiac catheterization.
10
EFNS guidelines on pharmacological treatment of neuropathic pain
Nadine Attal, G. Cruccu, Maija Haanpää et al. · European Journal of Neurology · 2006 · 872 citations
Depression and Functional Disability in Chronic Pediatric Pain
Susmita Kashikar‐Zuck, Kenneth R. Goldschneider, Scott W. Powers et al. · Clinical Journal of Pain · 2001 · 357 citations
Medicine, Child Health, Pediatrics +16
Clinical and prognostic features in unilateral femoral neuropathies
Thierry Küntzer, Guy van Melle, F Régli · Muscle & Nerve · 1997 · 103 citations
Multicultural Counseling and the Orthodox Jew
Eliezer Schnall · Journal of Counseling & Development · 2006 · 83 citations
Education, Counseling, Social Work +17